<section xmlns="http://xml.house.gov/schemas/uslm/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" style="-uslm-lc:I80" id="id7df9593c-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714"><num value="1714">§ 1714.</num><heading> Awards for demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through the use of drug testing and sanctions</heading><subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id7df9593d-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/a"><num value="a" class="bold">(a)</num><heading class="bold"> Awards required</heading><content><p style="-uslm-lc:I11" class="indent0">The Director shall make competitive awards to fund demonstration programs by eligible partnerships for the purpose of reducing the use of illicit drugs by chronic hard-drug users living in the community while under the supervision of the criminal justice system.</p>
</content>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id7df9593e-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/b"><num value="b" class="bold">(b)</num><heading class="bold"> Use of award amounts</heading><chapeau style="-uslm-lc:I11" class="indent0">Award amounts received under this section shall be used—</chapeau><paragraph style="-uslm-lc:I12" class="indent1" id="id7df9593f-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/b/1"><num value="1">(1)</num><content> to support the efforts of the agencies, organizations, and researchers included in the eligible partnership;</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="id7df95940-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/b/2"><num value="2">(2)</num><content> to develop and field a drug testing and graduated sanctions program for chronic hard-drug users living in the community under criminal justice supervision; and</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="id7df95941-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/b/3"><num value="3">(3)</num><content> to assist individuals described in subsection (a) by strengthening rehabilitation efforts through such means as job training, drug treatment, or other services.</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id7df98052-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c"><num value="c" class="bold">(c)</num><heading class="bold"> Eligible partnership defined</heading><chapeau style="-uslm-lc:I11" class="indent0">In this section, the term “eligible partnership” means a working group whose application to the Director—</chapeau><paragraph style="-uslm-lc:I12" class="indent1" id="id7df98053-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c/1"><num value="1">(1)</num><chapeau> identifies the roles played, and certifies the involvement of, two or more agencies or organizations, which may include—</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="id7df98054-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c/1/A"><num value="A">(A)</num><content> State, local, or tribal agencies (such as those carrying out police, probation, prosecution, courts, corrections, parole, or treatment functions);</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="id7df98055-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c/1/B"><num value="B">(B)</num><content> Federal agencies (such as the Drug Enforcement Agency, the Bureau of Alcohol, Tobacco, Firearms, and Explosives, and United States Attorney offices); and</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="id7df98056-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c/1/C"><num value="C">(C)</num><content> community-based organizations;</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="id7df98057-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c/2"><num value="2">(2)</num><content> includes a qualified researcher;</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="id7df98058-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c/3"><num value="3">(3)</num><content> includes a plan for using judicial or other criminal justice authority to administer drug tests to individuals described in subsection (a) at least twice a week, and to swiftly and certainly impose a known set of graduated sanctions for non-compliance with community-release provisions relating to drug abstinence (whether imposed as a pre-trial, probation, or parole condition or otherwise);</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="id7df98059-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c/4"><num value="4">(4)</num><content> includes a strategy for responding to a range of substance use and abuse problems and a range of criminal histories;</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="id7df9805a-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c/5"><num value="5">(5)</num><content> includes a plan for integrating data infrastructure among the agencies and organizations included in the eligible partnership to enable seamless, real-time tracking of individuals described in subsection (a);</content>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="id7df9805b-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/c/6"><num value="6">(6)</num><content> includes a plan to monitor and measure the progress toward reducing the percentage of the population of individuals described in subsection (a) who, upon being summoned for a drug test, either fail to show up or who test positive for drugs.</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id7df9805c-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/d"><num value="d" class="bold">(d)</num><heading class="bold"> Reports to Congress</heading><paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id7df9a76d-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/d/1"><num value="1" class="bold">(1)</num><heading class="bold"> Interim report</heading><content><p style="-uslm-lc:I12" class="indent1">Not later than <date date="2009-06-01">June 1, 2009</date>, the Director shall submit to Congress a report that identifies the best practices in reducing the use of illicit drugs by chronic hard-drug users, including the best practices identified through the activities funded under this section.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id7df9a76e-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/d/2"><num value="2" class="bold">(2)</num><heading class="bold"> Final report</heading><content><p style="-uslm-lc:I12" class="indent1">Not later than <date date="2010-06-01">June 1, 2010</date>, the Director shall submit to Congress a report on the demonstration programs funded under this section, including on the matters specified in paragraph (1).</p>
</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id7df9a76f-81bc-11eb-b838-b6993269d559" identifier="/us/usc/t21/s1714/e"><num value="e" class="bold">(e)</num><heading class="bold"> Authorization of appropriations</heading><content><p style="-uslm-lc:I11" class="indent0">There is authorized to be appropriated to carry out this section $4,900,000 for each of fiscal years 2007 through 2009.</p>
</content>
</subsection>
<sourceCredit id="id7df9a770-81bc-11eb-b838-b6993269d559">(<ref href="/us/pl/105/277/dC/tVII/s716">Pub. L. 105–277, div. C, title VII, § 716</ref>, as added <ref href="/us/pl/109/469/tXI/s1119">Pub. L. 109–469, title XI, § 1119</ref>, <date date="2006-12-29">Dec. 29, 2006</date>, <ref href="/us/stat/120/3547">120 Stat. 3547</ref>; amended <ref href="/us/pl/105/277/dC">Pub. L. 105–277, div. C</ref>. title VII, § 715, <date date="1998-10-21">Oct. 21, 1998</date>, <ref href="/us/stat/112/2681-693">112 Stat. 2681–693</ref>; <ref href="/us/pl/109/469/tVI/s602">Pub. L. 109–469, title VI, § 602</ref>, <date date="2006-12-29">Dec. 29, 2006</date>, <ref href="/us/stat/120/3533">120 Stat. 3533</ref>; <ref href="/us/pl/115/271/tVIII/s8202/a">Pub. L. 115–271, title VIII, § 8202(a)</ref>, (b)(2), <date date="2018-10-24">Oct. 24, 2018</date>, <ref href="/us/stat/132/4110">132 Stat. 4110</ref>.)</sourceCredit>
<notes type="uscNote" id="id7df9a771-81bc-11eb-b838-b6993269d559">
<note style="-uslm-lc:I74" role="crossHeading" topic="editorialNotes" id="id7df9a772-81bc-11eb-b838-b6993269d559"><heading class="centered"><b>Editorial Notes</b></heading></note>
<note style="-uslm-lc:I74" topic="amendments" id="id7df9a773-81bc-11eb-b838-b6993269d559"><heading class="centered smallCaps">Amendments</heading><p style="-uslm-lc:I21" class="indent0">2018—<ref href="/us/pl/115/271/s8202/b/2">Pub. L. 115–271, § 8202(b)(2)</ref>, repealed <ref href="/us/pl/105/277/s715">Pub. L. 105–277, § 715</ref>. See 1998 Amendment note below.</p>
<p style="-uslm-lc:I21" class="indent0"><ref href="/us/pl/115/271/s8202/a">Pub. L. 115–271, § 8202(a)</ref>, revived and restored this section as in effect on <date date="2003-09-29">Sept. 29, 2003</date>, and as amended by <ref href="/us/pl/109/469">Pub. L. 109–469</ref> and <ref href="/us/pl/112/166">Pub. L. 112–166</ref>. See Reauthorization of the Office of National Drug Control Policy note set out under <ref href="/us/usc/t21/s1701">section 1701 of this title</ref>.</p>
<p style="-uslm-lc:I21" class="indent0">2006—<ref href="/us/pl/109/469">Pub. L. 109–469</ref> amended <ref href="/us/pl/105/277/s715">Pub. L. 105–277, § 715</ref>, which provided for the repeal of this section. See 1998 Amendment note below.</p>
<p style="-uslm-lc:I21" class="indent0">1998—<ref href="/us/pl/105/277/s715">Pub. L. 105–277, § 715</ref>, as amended by <ref href="/us/pl/109/469/s602">Pub. L. 109–469, § 602</ref>, which provided for the repeal of this section effective <date date="2010-09-30">Sept. 30, 2010</date>, was repealed by <ref href="/us/pl/115/271/s8202/b/2">Pub. L. 115–271, § 8202(b)(2)</ref>. See former <ref href="/us/usc/t21/s1712">section 1712 of this title</ref>.</p>
</note>
</notes>
</section>